Brief: Tonix Pharmaceuticals Announces Pricing Of $4.0 Million Public Offering
12/06/2024 14:07
June 12 (Reuters) - Tonix Pharmaceuticals Holding Corp
TNXP.O :
* TONIX PHARMACEUTICALS ANNOUNCES PRICING OF $4.0 MILLION
PUBLIC
OFFERING
* TONIX PHARMACEUTICALS HOLDING: PLACEMENT AGENCY AGREEMENT
FOR
PURCHASE, SALE OF 3.8 MILLION SHARES AT OFFERING PRICE OF $1.065
PER SHARE
Source text for Eikon: ID:nGNX7FJ06x
Further company coverage: TNXP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tonix Pharmaceuticals Holding
See all newsBrief: Tonix Pharmaceuticals Says Dr. Reddy's Files ANDA With Paragraph IV Patent Certification For Generic Tonmya
Brief: Tonix Pharmaceuticals Announces Second Major Managed Medicare Payer Agreement For Tonmya®
Tonix Pharmaceuticals Holding Corp. reports results for the quarter ended June 30 - Earnings Summary
Tonix Q2 revenue rises sharply on TONMYA launch
Tonix Pharmaceuticals Holding Corp. expected to post a loss of $2.70 a share - Earnings Preview